Nanobiotix S.A. - Sponsored ADR

NBTX Healthcare Biotechnology

21.30 0.93 −4.18%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
3.40
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Dec '24 Jun '25 Dec '25 Jun '26
Cash and Short Term Investments

+8 more quarters

53.82 32.71 59.68 128.93
Receivables
3.22 2.09 2.42 2.25
Other current assets
9.47 10.48 8.90 12.39
Total current assets
66.51 45.28 71.00 143.57
Property, Plant, Equpment (Net)
17.92 5.52 19.24 5.13
Long-Term Investments
0.44 0.46 0.49 0.50
Goodwill and Intangible Assets (Total)
0.01 0.01 0.01 0.01
Total non-current assets
18.36 6.00 19.74 5.64
Total Assets
72.95 51.28 76.66 149.21
Accounts Payable
21.68 13.21 10.32 10.20
Current Part of Capital Lease
0.00 — 0.00 —
Current Part of Taxes to Pay
0.00 — 0.00 —
Current Revenue (Deferred)
— 0.06 — —
Other current liabilities
42.10 58.29 54.75 89.72
Total current liabilities
63.77 71.56 65.06 99.91
Non-current Revenue (Deferred)
0.00 — 0.00 —
Minority Interests
0.00 — 0.00 —
Non-current Liabilities (Other)
80.28 58.00 107.18 88.11
Total non-current liabilities
80.28 58.00 107.18 88.11
Total liabilities
144.05 129.56 172.25 188.02
Additional Paid In Capital
338.42 355.03 355.71 461.44
Preferred Stock (Total)
0.00 — 0.00 —
Common Stock (Net)
1.54 1.64 1.64 1.77
Retained Earnings
(73.73) (6.11) (27.11) (39.87)
Treasury Stock
0.25 0.26 0.26 0.27
Shareholders Equity (Other)
(337.08) (429.35) (425.57) (462.72)
Common Equity (Total)
(71.10) (78.27) (95.58) (38.81)
Shareholders Equity (Total)
(71.10) (78.27) (95.58) (38.81)
Shareholders Equity and Liabilities (Total)
72.95 51.28 76.66 149.21
Shares (Common)
— 48.24 — 50.83
Shareholders Equity (Tangible)
(71.11) (78.29) (95.59) (38.82)
Net Debt
(53.82) (32.71) (59.68) (128.93)

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 28 Sep 2026